Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

Your Location:Home>News Center

FDA Approves New Treatment Option for Patients with ALS

FDA Approves New Treatment Option for Patients with ALS SILVER SPRING, Md., Sept. 29, 2022. The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), com

FDA Approves Omlonti

FDA Approves Omlonti FDA Approves Omlonti (omidenepag isopropyl ophthalmic solution) for Reduction of Elevated Intraocular Pressure in Primary Open-Angle Glaucoma or Ocular Hypertension EMERYVILLE, Calif. & UBE, Japan--(BUSINESS WIRE) September 26, 20

Acupuncture May Ease Anxiety in Patients With Parkinson Disease

Acupuncture May Ease Anxiety in Patients With Parkinson Disease THURSDAY, Sept. 29, 2022 -- Acupuncture may help treat anxiety in patients with Parkinson disease and anxiety, according to a study published online Sept. 21 in JAMA Network Open. Jing-qi

FDA Approves Vtama

FDA Approves Vtama FDA Approves Vtama (tapinarof) Cream for the Treatment of Plaque Psoriasis in Adults LONG BEACH, Calif., and BASEL, Switzerland, May 24, 2022 — Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializ

Drug Therapy for Peds Psych Disorders, Later SUD Risk Examined

Drug Therapy for Peds Psych Disorders, Later SUD Risk Examined FRIDAY, May 27, 2022 -- Pharmacotherapy for pediatric psychiatric disorders possibly may reduce the risk for later substance use disorder (SUD), according to a review published online May 17

Exposure to Air Pollution Linked to Severe SARS-CoV-2 Outcomes

Exposure to Air Pollution Linked to Severe SARS-CoV-2 Outcomes FRIDAY, May 27, 2022 -- Chronic exposure to air pollution, especially ground-level ozone (O3), may contribute to severe outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-Co